Press Releases Autonomix Medical, Inc.

Equities

AMIX

US05330T1060

Market Closed - Nasdaq Other stock markets 12:59:36 05/06/2024 am IST			5-day change	1st Jan Change
1.9 ^USD	-6.86%		-7.77%	0.00%

03/06	Autonomix Medical, Inc. Announces Approval of Protocol Amendment by Ethics Committee Upon Completion of All Lead-In Patients in Ongoing Human Clinical Trial	CI
31/05	Autonomix Medical, Inc. Reports Earnings Results for the Full Year Ended March 31, 2024	CI

Press Releases

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Autonomix Announces Approval of Protocol Amendment by Ethics Committee Upon Completion of All Lead-In Patients in Ongoing Human Clinical Trial	03/06	AQ
Autonomix Medical, Inc. Reports Full Year 2024 Financial Results and Provides Corporate Update	31/05	AQ
Autonomix Preclinical Study Successfully Demonstrates That Nerve Ablation Can Slow Tumor Metastasis in Pancreatic Cancer	23/05	AQ
Autonomix Medical, Inc. (NASDAQ: AMIX) to Participate in the Virtual Investor Closing Bell Series	15/05	AQ
Autonomix Enters into Agreement with NoiseFigure Research, Inc. to Develop Next Generation of its Proprietary Microchip	25/04	AQ
Autonomix to Present at LIVE! with Webull Corporate Connect: Virtual Biotech Investment Webinar	24/04	AQ
Autonomix Medical Inc Covered in Benzinga Article Highlighting Innovative Nerve Treatment Tech	16/04	AQ
Autonomix Announces Issuance of U.S. Patent Covering Proprietary Catheter-Based Technology for the Treatment of Cancer Related Pain	16/04	AQ
Autonomix Medical Inc. Covered in Benzinga Article Highlighting Innovative Nerve Treatment Technology	15/04	AQ
Autonomix Announces Positive Findings from Preclinical Study Demonstrating Potential to Improve Renal Denervation	09/04	AQ
Autonomix to Participate in the Virtual Investor Lunch Break: The Team Behind the AMIX Ticker	08/04	AQ
Autonomix to Present at the MedInvest Biotech & Pharma Investor Conference	27/03	AQ
Autonomix (NASDAQ: AMIX) to Present at the Benzinga Virtual Healthcare Summit 2024	20/03	AQ
Autonomix Appoints Jennifer Cook as Chief Business Officer	19/03	AQ
Autonomix Completes First Three Patient Procedures in Human Clinical Trial Targeting Multi-Billion-Dollar Pancreatic Cancer Market	14/03	AQ
Autonomix Enrolls First Patients in Human Clinical Trial Targeting Multi-Billion-Dollar Pancreatic Cancer Market	06/03	AQ
Autonomix Signs Key Clinical Agreements in Preparation to Begin March 2024 Human Clinical Trial	29/02	AQ
Autonomix Medical, Inc. (NASDAQ: AMIX) to Participate in the Virtual Investor Lunch Break: The Autonomix Opportunity	23/02	AQ
Autonomix Secures Principal Investigators and Completes Clinical Training for First Human Study	22/02	AQ
Autonomix Begins Human POC Clinical Trial Targeting Multi-Billion-Dollar Pancreatic Cancer Market	16/02	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Autonomix Medical, Inc.

Equities

AMIX

US05330T1060

Press Releases

Filters